Wednesday, January 14, 2009

Important Changes to the Dose Conversion Guidelines for Fentanyl Transdermal Systems

From Health Canada:

The manufacturers of Fentanyl Transdermal Systems, in collaboration with Health Canada, are advising Canadians that important changes have been made to the dosage guidelines which are used to determine what dosage of Fentanyl Transdermal Systems is appropriate for each individual patient, and that this important safety information has been sent to all Canadian health care professionals and hospitals.
For Health Professionals
For the Public

No comments: